Satyen K. Bordoloi My first memory of cancer is the younger brother of a classmate. Blood cancer, we whispered between ...

On the roads, motor-vehicle deaths — which spiked during the pandemic — have now fallen for several years in a row: the ...

As of Tuesday, December 23, Editas Medicine, Inc.’s EDIT share price has dipped by 5.08%, which has investors questioning if this is right time to buy.

Cambodia border conflict, and the AI race are among the 10 prominent international events in 2025 as selected by the Vietnam News Agency.

From smartphones to artificial intelligence, technology moved from the margins of daily life to its center, transforming how ...

Cholesterol meds—taking by millions of Americans every day—often come with a lifelong prescription, adding out-of-pocket ...

NPR's Rob Stein explains why covering vaccines is no longer routine science journalism, but a political battleground.

Kayode Abidemi John is a pharmacist and a United States-based cancer researcher whose work focuses on prostate cancer at the Graduate School of Biomedical Sciences, University of Texas Health Science ...

Biotech today is moving at lightning speed, seriously. It feels like every week there’s something new that changes how we ...

In 2023, the AI market in pharmaceuticals and biotech was valued at $1.8 billion, and it’s expected to grow to $13.1 billion ...

Across sectors, tech majors worldwide blurred the line between experimental and practical, pushing the world into a new phase ...

Vertex recently said the product may deliver more than $100 million in revenue in the 2025 full year. But it's important to keep in mind that Vertex retains 60% of Casgevy profit while CRISPR ...